Depo-provera and Eczema exacerbated - a phase IV clinical study of FDA data

Summary:

Eczema exacerbated is reported as a side effect among people who take Depo-provera (medroxyprogesterone acetate), especially for people who are female, 10-19 old, have been taking the drug for 1 - 6 months also take Dupixent, and have Crohn's disease.

The phase IV clinical study analyzes which people have Eczema exacerbated when taking Depo-provera. It is created by eHealthMe based on reports of 15,804 people who have side effects when taking Depo-provera from the FDA, and is updated regularly.

What is Depo-provera?

Depo-provera has active ingredients of medroxyprogesterone acetate. It is often used in birth control. eHealthMe is studying from 17,093 Depo-provera users. Check the latest studies of Depo-provera.

What is Eczema exacerbated?

Eczema exacerbated is found to be associated with 1,253 drugs and 532 conditions by eHealthMe. Check the latest studies of Eczema exacerbated.

On Jul, 18, 2026

15,804 people reported to have side effects when taking Depo-provera.
Among them, 19 people (0.12%) have Eczema exacerbated.

Could Depo-provera cause Eczema exacerbated?

Among these 19 people:

How long have people been on Depo-provera when they have Eczema exacerbated? *

What is the gender of people who have Eczema exacerbated when taking Depo-provera? *

female: 94.74 %
male: 5.26 %

What is the age of people who have Eczema exacerbated when taking Depo-provera? *

What are other drugs people take besides Depo-provera? *

What are other side effects people have besides Eczema exacerbated? *

Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 4 people, 21.05%
Weight Increased: 4 people, 21.05%
Rashes (redness): 4 people, 21.05%
Fall: 4 people, 21.05%
Nausea And Vomiting: 3 people, 15.79%
Hypoaesthesia (reduced sense of touch or sensation): 3 people, 15.79%
Dyspnea (difficult or laboured breathing): 3 people, 15.79%
Headache (pain in head): 3 people, 15.79%
Gait Disturbance: 3 people, 15.79%
Diarrhea: 3 people, 15.79%

What are the existing conditions these people have? *

Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 3 people, 15.79%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 15.79%
Hidradenitis (chronic disease of a type of sweat gland): 2 people, 10.53%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 10.53%
High Blood Pressure: 2 people, 10.53%
Affective Disorder (mental disorder): 1 person, 5.26%
Back Disorder: 1 person, 5.26%
Bipolar Disorder (mood disorder): 1 person, 5.26%
Burning Sensation: 1 person, 5.26%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Depo-provera and have Eczema exacerbated?

- Check whether Eczema exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Depo-provera:

Depo-provera (17,093 reports)

Browse all side effects of Depo-provera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eczema exacerbated:

Eczema exacerbated (1,253 drugs)

Browse all the conditions that are associated with Eczema exacerbated:

Eczema exacerbated (532 conditions)

Related publications that referenced our studies

Bahall M, Reyes AJ, Ramcharan K, Hosein N, Seegobin K, Bahall K, Sharma H, Dhansingh S, Mahabir A, "Neuro-ophthalmological manifestations after intramuscular medroxyprogesterone: a forme fruste of idiopathic intracranial hypertension?", Neurology international, 2016 Sep .
Bahall M, Reyes AJ, Ramcharan K, Hosein N, Seegobin K, Bahall K, Sharma H, Dhansingh S, Mahabir A, "Neuro-ophthalmological manifestations after intramuscular medroxyprogesterone: a forme fruste of idiopathic intracranial hypertension?", Neurology international, 2016 Sep .

How the study uses the data?

The study uses data from the FDA. It is based on medroxyprogesterone acetate (the active ingredients of Depo-provera) and Depo-provera (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.